Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 451520, 8 pages
http://dx.doi.org/10.1155/2014/451520
Research Article

Long-Term Anabolic Androgenic Steroid Use Is Associated with Increased Atrial Electromechanical Delay in Male Bodybuilders

1Cardiology Department, Kartal Kosuyolu Heart Research and Training Hospital, Denizer Street, Kartal, 34846 Istanbul, Turkey
2Cardiology Department, Fatih University, Yalı Street, Maltepe, 34844 Istanbul, Turkey
3Cardiology Department, Kartal Yavuz Selim State Hospital, Yukarı Street, Kartal, 34860 Istanbul, Turkey

Received 26 February 2014; Accepted 14 April 2014; Published 4 May 2014

Academic Editor: Ken-ichi Aihara

Copyright © 2014 Mustafa Akçakoyun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Kanayama, J. I. Hudson, and H. G. Pope Jr., “Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?” Drug and Alcohol Dependence, vol. 98, no. 1-2, pp. 1–12, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Pärssinen and T. Seppälä, “Steroid use and long-term health risks in former athletes,” Sports Medicine, vol. 32, no. 2, pp. 83–94, 2002. View at Google Scholar · View at Scopus
  3. I. Thiblin and A. Petersson, “Pharmacoepidemiology of anabolic androgenic steroids: a review,” Fundamental and Clinical Pharmacology, vol. 19, no. 1, pp. 27–44, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Vanberg and D. Atar, “Androgenic anabolic steroid abuse and the cardiovascular system,” Handbook of Experimental Pharmacology, vol. 195, pp. 411–457, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. A. D'Andrea, P. Caso, G. Salerno et al., “Left ventricular early myocardial dysfunction after chronic misuse of anabolic androgenic steroids: a Doppler myocardial and strain imaging analysis,” British Journal of Sports Medicine, vol. 41, no. 3, pp. 149–155, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Nottin, L.-D. Nguyen, M. Terbah, and P. Obert, “Cardiovascular effects of androgenic anabolic steroids in male bodybuilders determined by tissue Doppler imaging,” American Journal of Cardiology, vol. 97, no. 6, pp. 912–915, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Krieg, J. Scharhag, T. Albers, W. Kindermann, and A. Urhausen, “Cardiac tissue doppler in steroid users,” International Journal of Sports Medicine, vol. 28, no. 8, pp. 638–643, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. L. Sullivan, C. M. Martinez, and E. J. Gallagher, “Atrial fibrillation and anabolic steroids,” Journal of Emergency Medicine, vol. 17, no. 5, pp. 851–857, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. D. H. Lau, M. K. Stiles, B. John, S. Shashidhar, G. D. Young, and P. Sanders, “Atrial fibrillation and anabolic steroid abuse,” International Journal of Cardiology, vol. 117, no. 2, pp. e86–e87, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. P. P. Pereira-Junior, E. A. Chaves, R. H. Costa-e-Sousa, M. O. Masuda, A. C. Campos de Carvalho, and J. H. M. Nascimento, “Cardiac autonomic dysfunction in rats chronically treated with anabolic steroid,” European Journal of Applied Physiology, vol. 96, no. 5, pp. 487–494, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Liu, M. Shehata, G. Li, and X. Wang, “Androgens and atrial fibrillation: friends or foes?” International Journal of Cardiology, vol. 145, no. 2, pp. 365–367, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. J.-C. Daubert, D. Pavin, G. Jauvert, and P. Mabo, “Intra- and interatrial conduction delay: implications for cardiac pacing,” Pacing and Clinical Electrophysiology, vol. 27, no. 4, pp. 507–525, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. Q.-Q. Cui, W. Zhang, H. Wang et al., “Assessment of atrial electromechanical coupling and influential factors in nonrheumatic paroxysmal atrial fibrillation,” Clinical Cardiology, vol. 31, no. 2, pp. 74–78, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. O. Kinay, C. Nazli, O. Ergene et al., “Time interval from the initiation of the electrocardiographic P wave to the start of left atrial appendage ejection flow: a novel method for predicting atrial fibrillation recurrence,” Journal of the American Society of Echocardiography, vol. 15, no. 12, pp. 1479–1484, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. C. B. de Vos, B. Weijs, H. J. G. M. Crijns et al., “Atrial tissue Doppler imaging for prediction of new-onset atrial fibrillation,” Heart, vol. 95, no. 10, pp. 835–840, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. M. Kalman, M. Munawar, A. Yapanis et al., “Atrial tachyarrhythmias following coronary bypass surgery: sympathetic mechanisms,” in Atrial Fibrillation, A Treatable Disease? J. H. Kingma, N. M. van Hemel, and K. I. Lie, Eds., pp. 211–225, Kluwer Academic Publishers, Dordrecht, The Netherlands, 1992. View at Google Scholar
  17. S. D. Pierdomenico, D. Lapenna, and F. Cuccurullo, “Risk of atrial fibrillation in dipper and nondipper sustained hypertensive patients,” Blood Pressure Monitoring, vol. 13, no. 4, pp. 193–197, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Solun, D. Marcoviciu, and D. Dicker, “Does treatment of hypertension decrease the incidence of atrial fibrillation and cardioembolic stroke?” European Journal of Internal Medicine, vol. 20, no. 2, pp. 125–131, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Burstein and S. Nattel, “Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation,” Journal of the American College of Cardiology, vol. 51, no. 8, pp. 802–809, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Fineschi, “Chronic, supra-physiological doses of nandrolone decanoate and exercise induced cardio-toxicity in an animal-model study,” Acta Physiologica, vol. 208, no. 2, pp. 141–143, 2013. View at Google Scholar
  21. M. Montisci, R. El Mazloum, G. Cecchetto et al., “Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases,” Forensic Science International, vol. 217, no. 1–3, pp. e13–e18, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. R. M. Lang, M. Bierig, R. B. Devereux et al., “Recommendations for chamber quantification: a report from the American Society of Echocardiography's guidelines and standards committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology,” Journal of the American Society of Echocardiography, vol. 18, no. 12, pp. 1440–1463, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. R. B. Devereux and N. Reichek, “Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method,” Circulation, vol. 55, no. 4, pp. 613–618, 1977. View at Google Scholar · View at Scopus
  24. S. F. Nagueh, C. P. Appleton, T. C. Gillebert et al., “Recommendations for the evaluation of left ventricular diastolic function by echocardiography,” Journal of the American Society of Echocardiography, vol. 22, no. 2, pp. 107–133, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. L. R. Peterson, A. D. Waggoner, K. B. Schechtman et al., “Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging,” Journal of the American College of Cardiology, vol. 43, no. 8, pp. 1399–1404, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Ozer, B. Yavuz, I. Can et al., “Doppler tissue evaluation of intra-atrial and interatrial electromechanicaldelay and comparison with P-wave dispersion in patients with mitral stenosis,” Journal of the American Society of Echocardiography, vol. 18, pp. 945–948, 2005. View at Google Scholar
  27. M. L. Sullivan, C. M. Martinez, P. Gennis, and E. J. Gallagher, “The cardiac toxicity of anabolic steroids,” Progress in Cardiovascular Diseases, vol. 41, no. 1, pp. 1–15, 1998. View at Google Scholar · View at Scopus
  28. S. Achar, A. Rostamian, and S. M. Narayan, “Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm,” American Journal of Cardiology, vol. 106, no. 6, pp. 893–901, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. M. S. Nieminen, M. P. Ramo, M. Viitasalo et al., “Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters,” European Heart Journal, vol. 17, no. 10, pp. 1576–1583, 1996. View at Google Scholar · View at Scopus
  30. W. Omi, H. Nagai, M. Takamura et al., “Doppler tissue analysis of atrial electromechanical coupling in paroxysmal atrial fibrillation,” Journal of the American Society of Echocardiography, vol. 18, no. 1, pp. 39–44, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. Ö. Esen, M. Akçakoyun, G. Açar et al., “Acute sleep deprivation is associated with increased atrial electromechanical delay in healthy young adults,” Pacing and Clinical Electrophysiology, vol. 34, no. 12, pp. 1645–1651, 2011. View at Google Scholar
  32. G. Acar, A. Akcay, A. Sokmen et al., “Assessment of atrial electromechanical delay, diastolic functions, and left atrial mechanical functions in patients with type 1 diabetes mellitus,” Journal of the American Society of Echocardiography, vol. 22, no. 6, pp. 732–738, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Roshanali, M. H. Mandegar, M. A. Yousefnia, F. Alaeddini, and B. Saidi, “Prevention of atrial fibrillation after coronary artery bypass grafting via atrial electromechanical interval and use of amiodarone prophylaxis,” Interactive Cardiovascular and Thoracic Surgery, vol. 8, pp. 421–425, 2009. View at Google Scholar
  34. B. Yavuz, A. Deniz, D. T. Ertugrul et al., “A novel echocardiographic marker in hypertensive patients: is diastolic dysfunction associated with atrial electromechanical abnormalities in hypertension?” Journal of Clinical Hypertension, vol. 12, no. 9, pp. 687–692, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Korantzopoulos, T. Kolettis, K. Siogas, and J. Goudevenos, “Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress,” Medical Science Monitor, vol. 9, no. 9, pp. RA225–RA229, 2003. View at Google Scholar · View at Scopus
  36. J.-J. Mercadier, D. De La Bastie, and P. Menasche, “Alpha-myosin heavy chain isoform and atrial size in patients with various types of mitral valve dysfunction: a quantitative study,” Journal of the American College of Cardiology, vol. 9, no. 5, pp. 1024–1030, 1987. View at Google Scholar · View at Scopus
  37. E. J. Benjamin, R. B. D'Agostino, A. J. Belanger, P. A. Wolf, and D. Levy, “Left atrial size and the risk of stroke and death: the Framingham Heart Study,” Circulation, vol. 92, no. 4, pp. 835–841, 1995. View at Google Scholar · View at Scopus
  38. A. C. Pearson, M. Schiff, and D. Mrosek, “Left ventricular diastolic function in weight lifters,” American Journal of Cardiology, vol. 58, no. 13, pp. 1254–1259, 1986. View at Google Scholar · View at Scopus
  39. B. de Piccoli, F. Giada, A. Benettin, F. Sartori, and E. Piccolo, “Anabolic steroid use in body builders: an echocardiographic study of left ventricle morphology and function,” International Journal of Sports Medicine, vol. 12, no. 4, pp. 408–412, 1991. View at Google Scholar · View at Scopus
  40. R. D. Dickerman, F. Schaller, N. Y. Zachariah, and W. J. McConathy, “Left ventricular size and function in elite bodybuilders using anabolic steroids,” Clinical Journal of Sport Medicine, vol. 7, no. 2, pp. 90–93, 1997. View at Google Scholar · View at Scopus
  41. F. Hartgens, E. Cheriex, and H. Kuipers, “Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletes,” International Journal of Sports Medicine, vol. 24, pp. 344–351, 2004. View at Google Scholar
  42. P. Palatini, F. Giada, G. Garavelli et al., “Cardiovascular effects of anabolic steroids in weight-trained subjects,” Journal of Clinical Pharmacology, vol. 36, no. 12, pp. 1132–1140, 1996. View at Google Scholar · View at Scopus
  43. P. D. Thompson, A. Sadaniantz, E. M. Cullinane et al., “Left ventricular function is not impaired in weight-lifters who use anabolic steroids,” Journal of the American College of Cardiology, vol. 19, no. 2, pp. 278–282, 1992. View at Google Scholar · View at Scopus
  44. N. Baris, T. Okan, O. Gurler et al., “Evaluation of left ventricular diastolic dysfunction with conventional and current Doppler techniques in Behcet's disease,” Clinical Rheumatology, vol. 25, no. 6, pp. 873–876, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. M. A. Allessie, P. A. Boyden, A. J. Camm et al., “Pathophysiology and prevention of atrial fibrillation,” Circulation, vol. 103, no. 5, pp. 769–777, 2001. View at Google Scholar · View at Scopus